Cargando…
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
As yet, no agents have been approved for the treatment of COVID-19, although several experimental drugs are being used off licence. These may have serious adverse effects and potential drug interactions with psychotropic agents. We reviewed the common agents being used across the world for the treat...
Autores principales: | Bishara, Delia, Kalafatis, Chris, Taylor, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309390/ https://www.ncbi.nlm.nih.gov/pubmed/32612804 http://dx.doi.org/10.1177/2045125320935306 |
Ejemplares similares
-
The interactions between COVID-19 drugs and psychotropic agents
por: Hiemke, C.
Publicado: (2021) -
Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies
por: Gatti, Milo, et al.
Publicado: (2021) -
Interactions of recommended COVID-19 drugs with commonly used psychotropics
por: Chatterjee, Seshadri Sekhar, et al.
Publicado: (2020) -
Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021) -
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
por: Bishara, Delia, et al.
Publicado: (2009)